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Ethnopharmacological  relevance:  Decoctions  or infusions  of the  stem  bark  of Byrsonima  japurensis  A. Juss.
(Malpighiaceae)  are  widely  used  as an  anti-inﬂammatory  drug  in folk  medicine  of  Amazonas  State  (Brazil).
Aim  of  the  study:  To  evaluate  the  pharmacological  potential  of an  aqueous  extract  of  the  stem  bark  of
Byrsonima  japurensis  (BJEA)  to  scientiﬁcally  verify  of  its traditional  use.
Materials and  methods:  Anti-inﬂammatory,  antihyperalgesic  and  antiulcer  activities  were  evaluated  in
Wistar rats,  a Hippocratic  screening  was  performed  in  Swiss  mice  to evaluate  the  toxic  effects,  and
antiplatelet  evaluation  was  performed  in  human  platelet  rich  plasma  assay.  Additionally,  antioxidant
activity  was  evaluated  by superoxide  radical  scavenging  method  and  -carotene  bleaching  test.
Results:  Anti-inﬂammatory,  antihyperalgesic  and  gastroprotective  activities  were  observed  in rats  treatedoxicity
mazonian
orally with  different  doses  of  BJEA.  While  signals  of  toxicity  were  observed  in  the  mice  treated  with  a
very high  dose  of extract  (5000  mg/kg),  no death  occurred.  BJEA  also  showed  expressive  antiplatelet  and
antioxidant  activities  in  vitro.
Conclusion:  According  to our results,  it  was  concluded  that  stem  bark  of  Byrsonima  japurensis  has  signiﬁ-
cant  and  safe  anti-inﬂammatory  activity,  which  is  closely  related  with  their  potent  antioxidant  activity,
supporting  the  folk  medicinal  use  of  this  species.
Crow. Introduction
Inﬂammation is a nonspeciﬁc response of the microcirculation
o tissue injury caused by physical, chemical or biological stimuli,
r some combination of these. However, when there is loss of
omeostatic control of this process of defense, inﬂammation plays
 damaging role that contributes to the appearance and worsening
f diseases (Nathan, 2002). The non-steroidal anti-inﬂammatory
rugs (NSAIDs) utilized in treatment of inﬂammation are one the
ost widely used classes of drugs throughout the world, but their
ndesirable side effects on gastric mucosa and cardiovascular sys-
em are well know (Wallace and Vong, 2008). Therefore, the search
or more effective anti-inﬂammatory drugs is still very relevant.
The use of plants as medicine dates back to early man. Often this
olk medicine is the only source of access for certain populations for
reating their diseases (Rates, 2001). However, the traditional use
f plants is not sufﬁcient for ethical validation of their therapeutic
∗ Corresponding author. Tel.: +55 9233055000; fax: +55 9233055000.
E-mail address: eslima@ufam.edu.br (E.S. Lima).
378-8741/$ – see front matter. Crown Copyright ©  2012 Published by Elsevier Ireland Lt
oi:10.1016/j.jep.2012.01.018n Copyright ©  2012 Published by Elsevier Ireland Ltd. All rights reserved.
effects, requiring scientiﬁc studies to verify their real pharmaco-
logical potential (McChesney et al., 2007).
The Byrsonima genus (Malpighiaceae) has about 150 species
with remarkable neotropical distribution. In various regions of
Brazil, several species of this genus are widely used in the treat-
ment of gastrointestinal complications. Various studies conﬁrmed
different biological activities in these plants, especially antioxidant,
antimicrobial, including action against bacteria, fungi and protozoa
and topical and systemic anti-inﬂammatory activities. Phytochem-
ically, this genus has being characterized by the presence of
ﬂavonoids and triterpenoids (Guilhon-Simplicio and Pereira, 2011).
Byrsonima japurensis A. Juss. (Malpighiaceae) is a tree found
in lowland areas of the Amazonian region used in folk medicine
in rural areas of Amazonas State (Brazil), where it is popularly
known as “saratudo” and considered a potent anti-inﬂammatory,
being used against pathologies of gastrointestinal and genitouri-
nary tracts. Normally, half a glass of tea prepared by decoction
or infusion done with about 5.0% of fragmented stem bark is
consumed once a day until the reduction of the symptoms of
inﬂammation, and, in more severe cases, twice. Alcoholic beverages
are also used in the preparation of folk medicines by maceration of
d. All rights reserved.
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he plant. For both cases, the raw material is previously dried in
he shade and its outer layer is scraped for removal of impurities.
owever, there is no present scientiﬁc data to support these uses.
Therefore this study intends to investigate pharmacological
ctivities of Byrsonima japurensis,  to contribute to the scientiﬁc
alidation of its popular use. For this, we evaluate the antiede-
atogenic, antihyperalgesic, antiplatelet, antiulcer and antioxidant
ctivities of an aqueous extract of stem bark of this plant. In addi-
ion, acute toxic potential was evaluated in animal experiments
n order to verify the safety of oral administration for therapeutic
urposes.
. Materials and methods
.1. Plant material
The collection of samples was authorized by the Managing
ouncil of the Genetic Patrimony (CGEN), chaired by the Ministry of
nvironment (Brazil), under the registration 034/2008. Stem bark of
yrsonima japurensis was collected in Careiro-Castanho, Amazonas,
razil, on March 2, 2007. The plant material was taxonomically
dentiﬁed and authenticated by José Lima of the Herbarium of
he Instituto Nacional de Pesquisas da Amazônia, where a voucher
pecimen (224415) was  deposited.
.2. Samples of human blood
The collection of samples of human blood was authorized by the
thical Committee on Research with Humans of the Universidade
ederal do Amazonas, under the registration 038/2006. The sam-
les were obtained from healthy adult volunteers of both genders.
.3. Animals
The tests with experimental animals were performed in accor-
ance with the Brazilian National Council for the Control of Animal
xperimentation. Female Wistar rats weighing 100–220 g and male
lbino Balb/c mice weighing 20–30 g were used in this study. The
nimals were housed in polypropylene cages at 25 ± 2 ◦C with 12 h
f a light-and-dark cycle and acclimatized in the experimental envi-
onment for at least 24 h before the tests. Water and a balanced diet
ere continually provided ad libitum,  but food was  withdrawn 12 h
efore the tests.
.4. Drugs and chemicals
Arachidonic acid, adenosine diphosphate, epinephrine and -
arrageenan was purchased from Fluka Chemical Company (Buchs,
witzerland); nitro blue tetrazolium (NBT), nicotinamide adenine
inucleotide (NADH) and phenazine methylsulfate (PMS) were
urchased from Chrono-Log Corporation (Havertown, PA, USA);
utylated hydroxytoluene (BHT), linoleic acid and -carotene was
urchased from Sigma–Aldrich (St. Louis, MO,  USA). Other reagents
ere purchased locally.
.5. Preparation of extract
In this study, the aim was to replicate the folk medicine usage
f the species when obtaining the crude extract. The stem bark
as dried at 40 ◦C in a stove (WHO, 2003), and then scraped and
ulverized using a mechanical grinder. The extract was obtained
y infusion with distilled water at 5% of plant material for 15 min
nd lyophilized for further use. The yield of extraction was  10.5%.
he extract obtained is named BJAE in this work.pharmacology 140 (2012) 282– 286 283
2.6. Hippocratic screening
The maximal dose of 5000 mg/kg of BJAE dissolved in normal
saline were administered orally to a group of ﬁve mice, observing
abnormal morphological and behavior signs of toxicity during the
ﬁrst 4 h after administration of extract and at every 24 h for 14 days
(Malone and Robichaud, 1962).
2.7. Anti-inﬂammatory activity
Doses of 100, 200 and 400 mg/kg of BJAE in normal saline were
administered orally in different groups of 6 rats. Two other groups
received indomethacin at 10 mg/kg (positive control) and normal
saline (negative control). After 1 h, a solution of -carrageenan 1% in
normal saline was  injected in the right hind paw of all animals, and
the paw edema progression was measured using a digital plethys-
mometer (LE-7500, Panlab, Barcelona, Spain), in hourly intervals,
for 5 h (Winter et al., 1962).
2.8. Anti-hyperalgesic activity
Different groups of 6 rats received were 100, 200 and 400 mg/kg
of BJAE in normal saline and indomethacin at 10 mg/kg (positive
control) and normal saline (negative control) utilized in each anal-
ysis. After 1 h, a solution of -carrageenan 1% in normal saline was
injected in the right hind paw of all animals and pressure stimuli
were applied on the inﬂamed paw at hourly intervals for 4 h, with
the maximal load borne by each animal registered by a digital anal-
gesimeter (EFF301, Insight, Ribeirão Preto, Brazil), in grams (Lapa
et al., 2008).
2.9. Antiulcer activity
Rats were organized in groups of six animals. Water was used
as a vehicle and negative control and ranitidine (50 mg/kg, by
oral route) was used as a positive control. Doses of 100, 200 and
400 mg/kg of BJAE were administered in three different groups.
After 1 h, indomethacin (10 mg/kg) was  subcutaneously adminis-
tered to all the animals. After 3 h, all the rats were sacriﬁced with
excess of anesthetic ether and their stomach was  cut open along
the lesser curvature, cleared of residual matter with saline and the
inner surface was  examined for ulceration and the ulcer index was
calculated (Djahanguiri, 1969).
2.10. Antiplatelet activity
This analysis was  performed in accordance with methodology of
Born (1962),  where different concentrations of BJAE are incubated
with platelet rich plasma obtained from human blood at 37 ◦C for
2 min. Arachidonic acid, adenosine diphosphate and epinephrine
were used as platelet inductors of platelet aggregation. Acetylsali-
cylic acid was  used as a positive control. The reading of results was
done in a Born aggregometer (PA-04, Qualiterm, São Paulo, Brazil).
2.11. Antioxidant activity
2.11.1. Superoxide radical scavenging test
Different concentrations of BJAE dissolved in 50% ethanol were
incubated for 5 min  in darkness with NBT, NADH and PMS  in a 96-
well plate, in triplicate. Ascorbic acid, gallic acid and -tocopherol
were used as positive controls. Ethanol at 50% was  used as a neg-
ative control. The absorbance was recorded at 560 nm to check
the bleaching of mixture, indicating the radical scavenging (Ozturk
et al., 2007).
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Fig. 1. Anti-inﬂammatory activity of Byrsonima japurensis.  (A) In early phase of84 F. Guilhon-Simplicio et al. / Journal o
.11.2. ˇ-Carotene bleaching test
Different concentrations of BJAE dissolved in dimethyl sulfox-
de (DMSO) were incubated with an emulsion of linoleic acid and
-carotene in water saturated with oxygen, for 15 min  at 50 ◦C in
 96-well plate, in triplicate. BHT was used as positive control and
MSO was used as a negative control. The absorbance was recorded
t 492 nm every 15 min  to check the bleaching of b-carotene, indi-
ating peroxidation (Miller, 1971).
.12. Statistical analysis
The results are presented as mean ± standard deviation,
hen applicable. Results of groups in antiedematogenic, anti-
yperalgesic and antiulcer tests were compared with a paired
tudent–Newman–Keuls test, considering values of p < 0.05 sta-
istically signiﬁcant. The median inhibitory concentrations (IC50)
f the antioxidant and antiplatelet activities were calculated by
inear regression method, and the statistical signiﬁcance of their
ifferences was measured with Student’s t-test.
. Results
.1. Hippocratic screening
The following symptoms were observed in all animals during
ippocratic screening of BJAE: decrease in motor activity, increase
n respiratory and cardiac frequency, dyspnea, palpebral ptosis,
ilomotor erection, cyanosis, and decrease in defecation, urination
nd appetite. However, no deaths occurred during the observation
eriod of 14 days and the animals recovered the normal parameters
ithin 48–72 h.
.2. Anti-inﬂammatory and antihyperalgesic activities
BJAE presented signiﬁcant antiedematogenic activity with 100,
00 and 400 mg/kg, in early phase (ﬁrst hour) and late phase (third
our) of inﬂammatory response induced by carrageenan, but the
ose of 400 mg/kg of extract presented signiﬁcantly higher antiede-
atogenic activity than the standard drug in the second phase
f carrageenan-induced inﬂammatory response (Fig. 1). In the
nalysis of anti-hyperalgesic activity, only the dose of 400 mg/kg
howed activity in both phases of carrageenan-induced inﬂamma-
ory response, with greater activity than the in positive control
Fig. 2).
.3. Anti-ulcer activity
The results of our test for evaluation of anti-ulcer activity
howed that doses of 100, 200 and 400 mg/kg of BJAE have signiﬁ-
ant gastroprotective action against indomethacin-induced gastric
esion. However, there were no differences within doses. Further-
ore, ranitidine 50 mg/kg tested in same conditions presented
etter protective effect on the gastric mucosa (Fig. 3).
.4. Antiplatelet activity
BJAE presented antiplatelet activity against different inductors
f aggregation, but its activity was not greater than acetylsalicylic
cid (AAS) tested in the same conditions. The IC50 of BJAE when
rachidonic acid, adenosine diphosphate and epinephrine were
sed as inductors of aggregation was 178.5 ± 1.6, 117.7 ± 4.5 and
7.5 ± 7.9 g/mL, respectively. For AAS, the results were 32.5 ± 0.2,
1.5 ± 1.4 and 11.7 ± 0.5, respectively. The difference between the
esults is statistically signiﬁcant, obtaining p-values smaller than
.01 in all the cases.carrageenan-induced paw edema and (B) in late phase of carrageenan-induced
paw edema; p-values versus negative control: *p < 0.05, **p  < 0.01, ***p < 0.001, and
p-values versus positive control: p < 0.05, p < 0.01.
3.5. Antioxidant activity
BJAE present signiﬁcant antioxidant activity in the superoxide
radical scavenging test. In this test, their IC50 was 42.5 ± 1.3 g/mL,
signiﬁcantly lower than -tocopherol (180.0 ± 14.2 g/mL) and
ascorbic acid (32.9 ± 1.6 g/mL) and higher than Gallic acid
(7.8 ± 1.2 g/mL). Its inhibition of lipid peroxidation was greater
than BHT tested in the same conditions, in which IC50 was  45.7 ± 3.1
and 81.6 ± 7.0 g/mL, respectively. The difference between the
results is also statistically signiﬁcant, obtaining p-values smaller
than 0.01 in all the cases.
4. Discussion
The inﬂammatory response produced by carrageenan is divided
into two  parts: the ﬁrst phase occurs within ﬁrst hour after polysac-
charide injection and is mainly related to the release of histamine,
serotonin, bradykinin, platelet activating factor and leukotrienes;
the second phase occurring within the ﬁrst and third hours (peak of
the inﬂammatory response) and is due to the release of prostanoids,
especially prostaglandins and prostacyclins, by the action of 1 and
2-cyclooxygenases (COX-1 and COX-2) (Vinegar et al., 1969). Dur-
ing any inﬂammatory response, usually innocuous stimuli produce
F. Guilhon-Simplicio et al. / Journal of Ethno
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pain, which is caused by the stimulation of afferent nervous ﬁbers
by action of kinins, serotonin, histamine, prostanoids, protons and
reactive species of oxygen (ROS) released during inﬂammation
(Scholz and Woolf, 2002).
Superoxide is the ﬁrst reduction product of molecular oxygen,
and it is an important source of hydroperoxides and deleterious
free radicals (Chauhan and Chauhan, 2006). This ROS is involved
in degenerative diseases of aging, including Alzheimer’s disease,
cancer and in the worsening of inﬂammatory diseases, such as
rheumatoid arthritis and atherosclerosis, through DNA and pro-
tein damage or lipid peroxidation (Ames et al., 1993; Wiseman and
Halliwell, 1996). It has been shown that lipid peroxidation is related
to the aggravation and acute and chronic inﬂammatory responses.
In vivo, this phenomenon is due mainly to the formation of per-
oxynitrite from the combination of superoxide radicals and nitric
oxide released during the inﬂammatory response (Salvemini et al.,
2006).
In humans and other species, the COX-1 is expressed con-
stitutively throughout the gastrointestinal tract (GI), where the
production of prostaglandin E2 (PGE2) and prostacyclin (PGI2) has
cytoprotective effects on the mucosa by reducing gastric acid secre-
tion by parietal cells in the stomach, increasing mucosal blood ﬂow,
and stimulating the release of viscous mucus (Rao and Knaus, 2008).
Gastric or duodenal ulcers develop in 15–30% of patients who  reg-
ularly take a non-steroidal anti-inﬂammatory drug (NSAID), which
inhibit the action of COX-1 (Borer and Simon, 2005).
The selective inhibitors of COX-2, the inducible isoform of
cyclooxygenase, were intended to be a safer alternative of NSAID
to gastrointestinal tract. However, these agents have been associ-
ated with undesirable effects on the cardiovascular system, such
as heart attacks and strokes, since that they do not inhibit throm-
bosis associated with release of thromboxane A2, a powerful
inductor of platelet aggregation, produced by COX-1 constitutively
present in all platelets, after platelet activation by collagen, adeno-
sine diphosphate (ADP), epinephrine, platelet activating factor,
arachidonic acid metabolites, polycations, serotonin and throm-
bin, among other substances involved in inﬂammatory response
(Weyrich et al., 2003; Sohn and Krötz, 2006).
The results of tests of anti-inﬂammatory and anti-hyperalgesic
activities showed that the effects of BJAE have a pattern similar to
the effect of indomethacin, an NSAID not selective for COX-1 or
COX-2, which also presented reduction of edema and pain in both
phases of carrageenan-induced inﬂammatory response, suggesting
a common mechanism of action between the drugs. This observa-
tion is reinforced by the results from the antiplatelet test, in which
BJAE was shown to have a good inhibitory effect against different
platelet inductors, suggesting that the extract is acting by a mech-
anism of inhibition common to all the inductors, such as inhibition
of COX-1 (Meadows and Bhatt, 2007).
The gastroprotective action against indomethacin-induced
gastric lesions suggests that the anti-inﬂammatory and anti-
hyperalgesic activities presented by BJAE are not only related to
the inhibition of cyclooxygenases, since the gastric lesions induced
by non-steroidal anti-inﬂammatory drugs (NSAIDs) depend of the
inhibition of both COX-1 and COX-2 (Wallace et al., 2000; Wallace
and Vong, 2008).
Therefore, the action of aqueous extract as a radical scavenger
of superoxide may  also contribute to its anti-inﬂammatory and
anti-hyperalgesic effect. Some studies showed that the removal of
superoxide has signiﬁcant anti-inﬂammatory effects, both preclin-
ically and clinically and it is a good strategy to inhibit peripheral
and central sensitization associated with several pain states (Wang
et al., 2004; Salvemini et al., 2006). Indeed, it is known that superox-
ides play a critical role in mediating the formation of peroxynitrite
in both early and late phases of the carrageenan-induced inﬂam-
matory response (Salvemini et al., 1996; Cuzzocrea et al., 1998).
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The signals of toxicity and/or pharmacological activity observed
n Hippocratic screening of BJAE are very similar to those presented
y Byrsonima crassifolia in two previous similar analyses (Guilhon-
implicio and Pereira, 2011). In the respective papers, the authors
uggest that the species has an effect on the central nervous sys-
em (CNS). This hypothesis should be further investigated, since the
ritical role of nicotinic acetylcholine receptors in the regulation of
nﬂammation has been established (Wang et al., 2003).
The results observed in this study can be partially explained
y the presence of different class of ﬂavonoids that we detected
n the species by phytochemical screening, high performance liq-
id chromatography, nuclear magnetic resonance and infrared
pectrometry ﬁngerprint (unpublished results). The capacity of
hese substances to inactivate enzymes involved in inﬂamma-
ory response, such phospholipases and cyclooxygenases and their
xpressive radical scavenging activity is well known (Middleton
t al., 2000). The increase in respiratory and cardiac frequency
bserved in Hippocratic screening can be explained by the pres-
nce of cardioactive heterosides which was also detected in the
ame study.
. Conclusion
This work met  its goal of scientiﬁcally verifying the popular use
f stem bark of Byrsonima japurensis,  whose tea is widely consumed
n folk medicine of Amazonas State (Brazil) as an anti-inﬂammatory
rug. The aqueous extract obtained by infusion at 5% of this vegetal
rug showed good antiedematogenic and anti-hyperalgesic poten-
ial after oral administration in animal experiments. Indeed, this
xtract also showed good antiplatelet and anti-ulcer activities that
ay  have fewer side effects compared to traditional NSAIDs. The
xpressive antioxidant action of extract, in addition to the already
ell-known beneﬁts to health, may  be contributing to its mecha-
ism of anti-inﬂammatory effect. It is important to highlight that
o death occurred after exposure to very high doses of BJAE, which
onﬁrmed the safety of its use for therapeutic purposes and for
dvancement of studies in vivo with this raw material. Therefore,
his species is a promising object for further studies aiming to sup-
ort its mechanism of pharmacological activities presented in this
ork.
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